Search Results - "van Manen, Labrinus"

Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study.

Authors: van Manen, Labrinus de Muynck, Lizzie D. A. N. Baart, Victor M. et al.

Source: Biomolecules (2218-273X). Apr2023, Vol. 13 Issue 4, p618. 10p.

Molecular-Targeted Fluorescence Lymph Node Imaging Could Play a Clinical Role in the Surgical Setting: A Systematic Review.

Authors: Zweedijk, Bo E. Dalmeijer, Sebastiaan W. R. van Manen, Labrinus et al.

Source: Cancers. Apr2025, Vol. 17 Issue 8, p1352. 26p.

Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis.

Authors: van Manen, Labrinus Groen, Jesse V. Putter, Hein et al.

Source: Biomarkers. Mar2020, Vol. 25 Issue 2, p186-193. 8p.

Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.

Authors: van Manen, Labrinus Stegehuis, Paulien L. Fariña-Sarasqueta, Arantza et al.

Source: PLoS ONE. 4/17/2017, Vol. 12 Issue 4, p1-15. 15p.

Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis.

Authors: van Manen, Labrinus Groen, Jesse V. Putter, Hein et al.

Source: Cancers. Oct2020, Vol. 12 Issue 10, p2970. 1p.

Indocyanine green fluorescence imaging improves the assessment of blood supply of interposition jejunum.

Authors: Lin Z Sun S Chen Y et al.

Source: Surgical endoscopy [Surg Endosc] 2022 Sep; Vol. 36 (9), pp. 6456-6463. Date of Electronic Publication: 2022 Jan 13.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8806653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2218 (Electronic) Linking ISSN: 09302794 NLM ISO Abbreviation: Surg Endosc Subsets: MEDLINE